key: cord-0031073-ma1f5za3 authors: Jung, Mi‐Hyang; Yi, Sang‐Wook; An, Sang Joon; Youn, Kwan‐Hyun; Yi, Jee‐Jeon; Han, Seongwoo; Ihm, Sang‐Hyun; Jung, Hae Ok; Youn, Ho‐Joong; Ryu, Kyu‐Hyung title: Association of Physical Activity and Lower Respiratory Tract Infection Outcomes in Patients With Cardiovascular Disease date: 2022-03-08 journal: J Am Heart Assoc DOI: 10.1161/jaha.121.023775 sha: e283e20bcaeec3557650b4f9c08deb1bd3ca40d5 doc_id: 31073 cord_uid: ma1f5za3 BACKGROUND: To investigate the dose‐response association between physical activity and lower respiratory tract infection (LoRI) outcomes in patients with cardiovascular disease. METHODS AND RESULTS: Using the Korean National Health Insurance data, we identified individuals aged 18 to 99 years (mean age, 62.6±11.3 years; women, 49.6%) with cardiovascular disease who participated in health screening from January 1, 2009, to December 31, 2012 (n=1 048 502), and were followed up until 2018 for mortality and until 2019 for hospitalization. Amount of physical activity was assessed using self‐reported questionnaires and categorized into 5 groups: 0 (completely sedentary), <500, 500 to 999, 1000 to 1499, and ≥1500 metabolic equivalents of task min/wk. After controlling for various confounders, adjusted hazard ratios (95% CIs) were 1.00 (reference), 0.74 (0.70–0.78), 0.66 (0.62–0.70), 0.52 (0.47–0.57), and 0.54 (0.49–0.60) for LoRI mortality, and 1.00 (reference), 0.84 (0.83–0.85), 0.77 (0.76–0.79), 0.72 (0.70–0.73), and 0.71 (0.69–0.73) for LoRI hospitalization among those engaging in physical activity of 0, <500, 500 to 999, 1000 to 1499, and ≥1500 metabolic equivalents of task min/wk, respectively. Assuming linear association between 0 and 2000 metabolic equivalents of task min/wk, each 500–metabolic equivalents of task min/wk increase of physical activity was associated with reduced LoRI mortality and hospitalization by 22% and 13%, respectively. The negative association was stronger in the older population than in the younger population (P for interaction <0.01). CONCLUSIONS: In patients with cardiovascular disease, engaging in even a low level of physical activity was associated with a decreased risk of mortality and hospitalization from LoRI than being completely sedentary, and incremental risk reduction was observed with increased physical activity. Physical Activity and LoRI Outcomes respiratory tract infection and physical activity are mostly for general population and mainly focused on upper respiratory tract infection with a benign clinical course. [11] [12] [13] [14] [15] [16] [17] Among the studies on LoRI, inconsistent data exist. [11] [12] [13] 15 Specifically, it is not clear whether a low level of physical activity, performed less than the minimum amount suggested in the guidelines, 5, 6 could lower the risk of LoRI. Clarifying the doseresponse association between physical activity and LoRI would be helpful to guide patients with CVD about proper physical activity. Moreover, during the recent outbreak of the COVID-19 pandemic, individuals have been advised to stay indoors and limit their physical/social activity. Although such restrictions may be useful to control the spread of COVID-19, they can unintentionally decrease the amount of physical activity. Therefore, elucidating the relationship between physical activity and LoRI outcomes in patients with CVD would be of value for improving prognoses in future pandemics and related LoRIs. 18 Using a population-based cohort study with >1 million patients with CVD, we aimed to investigate the dose-response association between physical activity and LoRI outcomes (mortality and hospitalization). Specifically, we sought to identify whether there is still some beneficial effect associated with a lower level of physical activity than the minimum level suggested in the guidelines (<500 metabolic equivalents of task [MET] min/wk). 5 In addition, we evaluated whether the association differs by age, with a focus on older patients. Because of the sensitive nature of the data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to National Health Insurance Service (NHIS) of Korea at https://nhiss.nhis. or.kr/bd/ab/bdaba 021eng.do. The current study used data from the NHIS. The NHIS provides mandatory health insurance, covering up to 97% of the Korean population. Details about the database are described elsewhere. 19 Among participants of NHIS health screening from 2009 to 2012, those aged 18 to 99 years with prevalent CVD, defined by ischemic heart disease (International Classification of Diseases, Tenth Revision , code of I20-I25), heart failure (ICD-10 code of I11, I13, I255, I42, or I50), or cerebrovascular disease (ICD-10 code of I60-I69), including stroke (ICD-10 code of I60-I64 or I69), were identified as the study cohort (n=1 188 635). These 3 major CVDs were chosen as they are frequently used as clinical end point or study population. 10, 20 We considered individuals to have prevalent disease at baseline if they visited a medical institution for the disease at least once within 12 months before the baseline health examination date. Among the study cohort (n=1 188 635), we excluded 136 438 people with preexisting cancers and other miscellaneous diseases, and 3695 individuals because of missing information on the date of health examination and risk factors, including body mass index, fasting glucose, and systolic blood pressure. Finally, for the remaining 1 048 502 patients, follow-up for death and hospitalization attributable to LoRI (ICD-10 code of J09-J22; influenza, pneumonia, and other LoRI) was performed until December 31, 2018, through national death records, and until December 31, 2019, through the NHIS claim database. The Institutional Review Board of Catholic Kwandong University, Republic of Korea, approved the study; and the informed consent was waived because anonymized data were provided by the NHIS according to a strict confidentiality protocol. What Is New? • The present study demonstrated a graded negative dose-response association of physical activity on mortality and hospitalization attributable to lower respiratory tract infection in individuals with cardiovascular disease, including older individuals. • Engaging in even a low amount of physical activity was associated with a reduced risk compared with being completely sedentary. • Furthermore, incremental risk reduction was demonstrated with increasing physical activity. What Are the Clinical Implications? • The dose-response association analyses support the need to limit sedentary behaviors and gradually increase physical activity as medical condition allows to meet the guideline-suggested goal. • This could be an attainable approach among patients with cardiovascular disease, especially for older patients. Body mass index (kg/m 2 ) was calculated as measured weight divided by the square of measured height. Blood pressure was measured in a seated position after resting for at least 5 minutes. Fasting glucose was assayed by enzymatic methods. Smoking history, alcohol use, and physical activity were self-reported via a questionnaire at the time of health examination. Health examination and data collection followed a standard protocol by the government. The medical institutions for screening that met the standards of personnel, facilities, and equipment were selected according to the law. 19 The external quality validation process for clinical chemistry was performed regularly. Information on prevalent diseases (eg, CVD and chronic obstructive pulmonary disease [ICD-10 codes of J40-J44 or J47; outpatient visit or hospitalization]) and previous hospitalization for LoRI within 12 months before the baseline health examination date was assessed through the NHIS claims database. Physical activity was assessed using the NHIS questionnaire based on the modified International Physical Activity Questionnaire, which has shown moderately good validity and reliability compared with accelerometer assessment. 21 The expected associations between physical activity (assessed with the NHISmodified International Physical Activity Questionnaire questionnaire) and several outcomes have been reported in previous studies. 10, 22 The English-translated questionnaire is available elsewhere. 22 In brief, based on 7-day recall method, the questionnaire evaluated the frequency of each of the following 3 intensity leisure time physical activities (expressed as 0 to 7 days per week): (1) number of days performing light-intensity physical activity for at least 30 minutes (eg, walking at a leisurely pace), (2) number of days performing moderate-intensity physical activity for at least 30 minutes (eg, fast walking, tennis, or bicycle riding), and (3) number of days performing vigorous-intensity physical activity for at least 20 minutes (eg, running, aerobics, high-speed cycling, or mountain hiking). We calculated the total energy expenditure (MET min/wk) by summing the product of frequency, duration, and assigned values for each of the 3 intensity physical activities. For the intensity of each physical activity, we assigned 2.9, 4.0, and 7.0 MET for light, moderate, and vigorous physical activity, respectively. 10 For the main analyses, study populations were categorized into 5 groups by their amount of physical activity: 0 (completely sedentary), <500, 500 to 999, 1000 to 1499, and ≥1500 MET min/wk. In addition, to characterize the association between moderate to vigorous physical activity (MVPA) and outcome, the study population was categorized into 4 groups by their MVPA frequency: 0, 1 to 2, 3 to 4, and ≥5 times/week. The hazard ratios (HRs) and CIs associated with physical activity for deaths and hospitalization attributable to LoRI were calculated using a Cox proportional hazards model. In the multivariable models, adjustments were made for age at baseline (continuous variable; within each age group), sex, smoking status (current smoker, former smoker, nonsmoker, and missing information), frequency of alcohol use (none, <10, 10-39, or ≥40 g ethanol/d, and missing information), beneficiary income status (quantiles), body mass index (<18.5, 18.5-24.9, 25-29.9, or ≥30 kg/m 2 ), hypertension (systolic blood pressure <120, 120-139, or ≥140 mm Hg or prevalent hypertension), diabetes (fasting glucose <100, 100-125, or ≥126 mg/dL or prevalent diabetes), prevalent chronic obstructive pulmonary disease, and previous admission attributable to LoRI. In the Cox model for LoRI mortality, the cause-specific hazard method was used for handling competing risks; individuals who experienced a competing event (other causes of death) or reached the end of follow-up were treated as censored. Schoenfeld residuals were used to test the proportional hazard assumption. Subgroup analyses by age strata, sex, and CVD subtypes were also performed. To validate the age-specific association (particularly associations in older patients with CVD), we stratified patients by age strata (18-64, 65-74, and 75-99 years). Sensitivity analyses were conducted that excluded the first 2 years of follow-up. Analysis using physical activity as a continuous variable (per 500-MET min/wk increase) was performed. The Cochran Q statistic was used as the interaction test to examine the difference in the effect size of each 500-MET min/ wk increment between age groups. HRs of restricted cubic spline transformation of MET min/wk with 4 knots (5th, 50th, 85th, and 97.5th percentile) and 0 MET min/ wk as a reference were also plotted. All P values were 2 sided. All analyses were conducted using SAS version 9.4 software (SAS Institute, Cary, NC). The dose-response association demonstrated a graded negative association between physical activity and LoRI outcomes. Compared with completely sedentary individuals, a reduced risk was found in those who performed <500 MET min/wk of physical activity. Table 2 ). Survival plots showed that separation of the curve between those completely sedentary and those with <500 MET min/wk began early ( Figure 1) . A similar dose-response association was observed for the MVPA frequency. Compared with individuals who never performed MVPA (including individuals who performed only light-intensity physical activity [n=278 573]), a gradual risk reduction was observed in those who performed MVPA up to 3 to 4 times/week but without further risk reduction in those performed MVPA ≥5 times/week; multivariate-adjusted HRs (95% CIs) were 1. (Table S1) . Subgroup analyses by age strata, sex, and CVD subtype generally yielded similar results (Tables S2 and S3) . Particularly, when participants were stratified by age, a gradual risk reduction was evident among older patients (aged ≥65 years), including those aged 75 to 99 years. Moreover, the effect size was larger in the older than in the younger population (P for interaction [age] <0.001). Sensitivity analyses that excluded the first 2 years of follow-up were similar to the main analyses (Table S4) . Further controlling for prevalent asthma, outpatient clinic visits attributable to LoRI, and previous use of steroids, which act as sensitivity analyses, did not virtually alter the results (Table S5) . Assuming linear association (between 0 and 2000 MET min/wk of physical activity), each 500-MET min/wk increase of physical activity was associated with 22% and 13% reduced risk of LoRI mortality and hospitalization in the overall population, respectively, in the fully adjusted model. The association strength increased as age increased. For example, a 500-MET min/wk increase of physical activity was associated with 25% and 16% reduced risk of LoRI mortality and hospitalization, respectively, in individuals aged 75 to 99 years ( Figure 2 and Table S6 ). In the restricted cubic spline analyses, the pattern was generally parallel to that from categorical analyses ( Figure 3 ). The risk declined gradually with increased physical activity up to 1500 to 1800 MET min/wk, and the curve flattened beyond that level. The overall pattern was similar, except for a relatively smaller effect size and narrower CI for hospitalization than mortality. The present study demonstrated a negative doseresponse association of physical activity on mortality and hospitalization attributable to LoRI in >1 million people with CVD. Engaging in even a low amount of physical activity was associated with a reduced risk compared with being completely sedentary. Furthermore, incremental risk reduction was demonstrated with increasing physical activity ( Figure 4) . Moreover, the dose-response association was more evident in older individuals than in younger individuals with CVD. The current study evaluated the dose-dependent association of physical activity with LoRI outcomes. Less attention has been paid to the effect of physical activity on LoRI outcomes. The NHS (Nurses' Health Study) II demonstrated a graded inverse association between physical activity and pneumonia, although the association was unclear after controlling for obesity, smoking, and alcohol consumption. 11 This might be partly because they enrolled younger adults (aged 27-44 years), and event rates were relatively low. The National Walkers' and Runners' Health Studies (NWHS and NRHS) 12 showed an inverse dose-response relationship between physical activity and mortality from pneumonia after controlling for covariates, similar to our study. Notably, we found that older adults had stronger associations than younger adults. A previous study in Hong Kong reported that the beneficial effect of physical activity for influenza was more evident in younger than in older adults; however, the CIs of the effect between age groups overlapped. 15 The age-specific Jung et al Physical Activity and LoRI Outcomes A recent cohort study demonstrated a beneficial effect of physical activity on all-cause and various cause-specific mortalities, including influenza and pneumonia-related mortality. 14 However, that study did not evaluate the effect of physical activity that does not satisfy the guideline-recommended amount. Notably, our study demonstrated that participating in a low level of physical activity is beneficial compared with being completely sedentary, even though it does not meet the physical activity guidelines. This could have clinical implications given that many people with CVD (especially older individuals) did not meet the recommended amount. Indeed, more than half of the study population had <500 MET min/wk, and two thirds of individuals engaging in 1 to 499 MET min/wk only performed lightintensity physical activity. Conflicting data exist on the association of high physical activity levels with respiratory tract infection outcomes. [11] [12] [13] 16, 17 In some studies, an excess risk of extreme physical activity levels was shown for those who underwent strenuous activity, such as running a marathon, particularly among younger adults. However, there was no harm at the highest physical activity level in the present study. This might be because most patients with CVD in our study were older individuals who participated in physical activity for recreational purposes, not for competition. Moreover, the excess risk in those studies was mostly for immediate events after competitive exercise for upper respiratory tract infection, 16 not for LoRI. To the best of our knowledge, this is the largest cohort study with substantial follow-up that explicitly explored the association of physical activity with LoRI in individuals with CVD. The dose-response association analyses support the need to limit sedentary behaviors and gradually increase physical activity (as medical condition allows) to meet the guideline-suggested goal. 5, 6, 25 This could be an attainable approach among patients with CVD and older adults. Although we described the improvement of risk associated with lower amount of physical activity, we should not overlook the incremental benefit of activity that meets the physical activity guidelines. 5, 6, 25 In other words, if the lower amount of physical activity is beneficial, sufficient physical activity would be more beneficial for LoRI outcomes. To this end, each patient with CVD should be advised about an appropriate intensity, frequency, and duration of physical activity for better LoRI outcomes. 25 Furthermore, a recent guideline on exercise in patients with CVD also emphasized risk stratification before participation in exercise and individualized physical activity prescription among patients with CVD. 25 The current study did not directly show the association between physical activity and COVID-19 outcomes. However, a recent study demonstrated that inconsistently as well as consistently performing physical activity was associated with lower risk for severe COVID-19 outcomes. 26 Encouraging physical activity while following the safety rules (eg, wearing a mask and keeping a safe distance) might be beneficial to improve prognosis during COVID-19 and future pandemics. The underlying mechanism for the inverse association of physical activity on LoRI is yet to be determined. Presumably, enhanced immunity, modulated inflammatory response, and improved lung function might play a role. [27] [28] [29] [30] [31] [32] Previous studies showed that natural killer cell activity (reflecting innate immune system) is higher in physically active individuals than in sedentary people. 27 Moreover, increased chronic inflammation coupled with oxidative stress could weaken the diaphragm muscle force, 32 which could be recovered by participating in physical activity. Although the immediate effect of a single bout of strenuous physical activity remains controversial, the long-term effect of physical activity performed on a regular basis is beneficial for both CVD and respiratory infection throughout the lifespan. 28 Data are expressed as mean±SD or number (percentage). COPD indicates chronic obstructive pulmonary disease; FBG, fasting blood glucose; MET, metabolic equivalents of task; and SBP, systolic blood pressure. The limitations of the present study include the observational study design, which makes causal inference difficult. Although we extensively controlled for various confounders, unavailable potential confounders and residual confounding might affect the study outcomes to some degree. Reverse causality The amount of physical activity was categorized into 5 groups (0, 1-499, 500-999, 1000-1499, and ≥1500 metabolic equivalents of task min/wk). To create the survival plots for lower respiratory tract infection mortality; (A) and lower respiratory tract infection hospitalization (B), multivariate-adjusted Cox regression was used (adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, body mass index, prevalent chronic obstructive pulmonary disease, and history of admission attributable to lower respiratory tract infection). Assuming linear association between 0 and 2000 MET min/wk of physical activity, each 500-MET min/wk increase of physical activity was associated with 22% and 13% reduced risk of lower respiratory tract infection mortality and hospitalization in the overall population in the fully adjusted model. Of note, the strength of association increased as age increased. HR indicates hazard ratio. Physical Activity and LoRI Outcomes (namely, physical inactivity as a possible reflection of worse disease condition) should be considered. Although the results remained robust after the exclusion of the first 2 years of follow-up, the possibility of reverse causality cannot be completely eliminated. Furthermore, the level of physical activity might have been changed over time; thus, the baseline physical activity may not be enough to capture the actual physical activity level during the follow-up. Physical activity assessment was performed using a selfreported questionnaire. Compared with objective assessment using accelerometers, our assessment The shape of association between physical activity and lower respiratory infection outcomes for mortality (A) and for hospitalization (B) demonstrated a nonlinear association (L-shaped association). The risk declined gradually with increased physical activity up to 1500 to 1800 metabolic equivalents of task (MET) min/wk, and the curve flattened beyond that level without additional risk lowering or elevation. Hazard ratios were adjusted for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, body mass index, known chronic obstructive pulmonary disease, and history of admission attributable to lower respiratory tract infection. was more prone to misclassification. Nonetheless, self-reported questionnaires were used in large studies as in the current study. 33 There is a chance of misclassification of LoRI outcomes as our study made use of ICD-10 codes. However, the diagnostic accuracy of ICD-10 codes for pneumonia, the most important LoRI outcome, was found to be acceptable (85.6%) compared with medical records. 34 In addition, information on muscle strengthening exercise was unavailable. The study results may not be directly applied to all spectrums of CVD (such as valvular heart disease, arrhythmia, and cardiomyopathy). Finally, the findings may be interpreted in the context of the Korean population, showing different metabolic traits and cultural norms. Therefore, subsequent studies of patients with CVD from other races and ethnicities could be valuable. Physical activity has a graded negative dose-dependent association with LoRI morbidity and mortality in individuals with CVDs, including older individuals. Of note, our study demonstrated that engaging in even a low level of physical activity leads to a reduced risk than remaining completely sedentary. Moreover, the risk reduction was incremental according to the increasing amount of physical activity. Abbreviations: CI, confidence interval; HR, hazard ratio; MET, metabolic equivalents of task. * HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, and household income. † HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, body mass index, known chronic obstructive lung disease, and previous history of admission due to lower respiratory tract infection. Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HF, heart failure; HR, hazard ratio; IHD, ischemic heart disease; n/a, non-applicable; MET, metabolic equivalents of task; MV, multivariate. * HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, known chronic obstructive lung disease, and previous history of admission due to lower respiratory tract infection. Abbreviations: CI, confidence interval; HR, hazard ratio; MET, metabolic equivalents of task. * HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, body mass index, known chronic obstructive lung disease, and previous history of admission due to lower respiratory tract infection. † HRs were calculated by Cox models, after adjusting for all variables in main analysis, prevalent asthma, outpatient clinic visit due to influenza and pneumonia, and steroid use within 1 year before the health examination date. Abbreviations: CI, confidence interval; HR, hazard ratio; MET, metabolic equivalents of task. * HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, and household income. † HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, body mass index, prevalent chronic obstructive lung disease, and previous history of admission due to lower respiratory tract infection. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship The physical activity guidelines for Americans World Health Organization 2020 guidelines on physical activity and sedentary behaviour The compelling link between physical activity and the body's defense system Burden of pneumonia-associated hospitalizations: United States Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study Mortality reduction with physical activity in patients with and without cardiovascular disease Physical activity and the risk of community-acquired pneumonia in US women Dose-response relationship between exercise and respiratory disease mortality Associations of daily walking time with pneumonia mortality among elderly individuals with or without a medical history of myocardial infarction or stroke: findings from the Japan Collaborative Cohort Study Recommended physical activity and all cause and cause specific mortality in US adults: prospective cohort study Physical activity and influenzacoded outpatient visits, a population-based cohort study Infectious episodes before and after a marathon race Exercise and respiratory tract viral infections Physical activity for immunity protection: inoculating populations with healthy living medicine in preparation for the next pandemic Cohort profile: the National Health Insurance Service-National Health Screening Cohort Impact of high-normal blood pressure on the risk of cardiovascular disease International physical activity questionnaire: 12-country reliability and validity Physical activity frequency and the risk of stroke: a Nationwide Cohort Study in Korea Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults Age-specific associations between systolic blood pressure and cardiovascular mortality 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients Healthy lifestyles are associated with higher natural killer cell activity Aerobic fitness is associated with lower proportions of senescent blood T-cells in man Debunking the myth of exercise-induced immune suppression: redefining the impact of exercise on immunological health across the lifespan Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure Effect of exercise training on chronic inflammation Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants Enhancement and Assessment of the Agreement Between Medical Records and Disease Codes of National Health Insurance Claim Data: the Final Report Abbreviations: CI, confidence interval; CVD, cardiovascular disease IHD, ischemic heart disease; MET, metabolic equivalents of task * HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, and household income † HRs were calculated by Cox models, after adjusting for age at baseline, sex, smoking status, alcohol consumption frequency, household income, blood pressure status, fasting glucose status, known chronic obstructive lung disease, and previous history of admission due to lower respiratory tract infection The authors would like to thank the staff at the Big Data Steering Department at National Health Insurance Service for providing data and support. This research was supported by a grant from the Korean Society of CardioMetabolic Syndrome. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. None. Tables S1-S6